Pharmacoepidemiology and Drug Safety

Cover image for Pharmacoepidemiology and Drug Safety

May/June 1992

Volume 1, Issue 3

Pages fmi–fmi, 107–165

  1. Masthead

    1. Top of page
    2. Masthead
    3. Editorial
    4. Original Reports
    5. Methodology
    6. Original Reports
    7. Reviews
    8. Original Reports
    9. Reviews
    10. Public Policy
    11. Letter to the Editor
    1. Masthead (page fmi)

      Version of Record online: 12 JAN 2006 | DOI: 10.1002/pds.2630010301

  2. Editorial

    1. Top of page
    2. Masthead
    3. Editorial
    4. Original Reports
    5. Methodology
    6. Original Reports
    7. Reviews
    8. Original Reports
    9. Reviews
    10. Public Policy
    11. Letter to the Editor
    1. Editorial (pages 107–108)

      Version of Record online: 12 JAN 2006 | DOI: 10.1002/pds.2630010302

    2. Editor's note (page 109)

      Version of Record online: 12 JAN 2006 | DOI: 10.1002/pds.2630010303

  3. Original Reports

    1. Top of page
    2. Masthead
    3. Editorial
    4. Original Reports
    5. Methodology
    6. Original Reports
    7. Reviews
    8. Original Reports
    9. Reviews
    10. Public Policy
    11. Letter to the Editor
    1. Safety of fluoxetine: Comparison with fluvoxamine (pages 111–117)

      John Price, Patrick Waller, Susan Wood and Angus MacKay

      Version of Record online: 12 JAN 2006 | DOI: 10.1002/pds.2630010304

    2. Rate of venereal disease goinfections in women with vaginal candidiasis: Michigan medicaid (pages 125–132)

      Carol Brignoli Gable, Susan Sedory Holzer, Luella Engelhart, Syam Sarma, Frank Smeltz, Donald A. Schroeder and Rhonda B. Friedman

      Version of Record online: 12 JAN 2006 | DOI: 10.1002/pds.2630010306

  4. Methodology

    1. Top of page
    2. Masthead
    3. Editorial
    4. Original Reports
    5. Methodology
    6. Original Reports
    7. Reviews
    8. Original Reports
    9. Reviews
    10. Public Policy
    11. Letter to the Editor
  5. Original Reports

    1. Top of page
    2. Masthead
    3. Editorial
    4. Original Reports
    5. Methodology
    6. Original Reports
    7. Reviews
    8. Original Reports
    9. Reviews
    10. Public Policy
    11. Letter to the Editor
  6. Reviews

    1. Top of page
    2. Masthead
    3. Editorial
    4. Original Reports
    5. Methodology
    6. Original Reports
    7. Reviews
    8. Original Reports
    9. Reviews
    10. Public Policy
    11. Letter to the Editor
    1. Experience of a premarketing alert (pages 143–145)

      M. O. East

      Version of Record online: 12 JAN 2006 | DOI: 10.1002/pds.2630010309

  7. Original Reports

    1. Top of page
    2. Masthead
    3. Editorial
    4. Original Reports
    5. Methodology
    6. Original Reports
    7. Reviews
    8. Original Reports
    9. Reviews
    10. Public Policy
    11. Letter to the Editor
  8. Reviews

    1. Top of page
    2. Masthead
    3. Editorial
    4. Original Reports
    5. Methodology
    6. Original Reports
    7. Reviews
    8. Original Reports
    9. Reviews
    10. Public Policy
    11. Letter to the Editor
  9. Public Policy

    1. Top of page
    2. Masthead
    3. Editorial
    4. Original Reports
    5. Methodology
    6. Original Reports
    7. Reviews
    8. Original Reports
    9. Reviews
    10. Public Policy
    11. Letter to the Editor
  10. Letter to the Editor

    1. Top of page
    2. Masthead
    3. Editorial
    4. Original Reports
    5. Methodology
    6. Original Reports
    7. Reviews
    8. Original Reports
    9. Reviews
    10. Public Policy
    11. Letter to the Editor
    1. Letter (page 163)

      Robert P. Hirsch

      Version of Record online: 12 JAN 2006 | DOI: 10.1002/pds.2630010313

    2. Letter (page 165)

      K. Beard

      Version of Record online: 12 JAN 2006 | DOI: 10.1002/pds.2630010314

SEARCH

SEARCH BY CITATION